Bending Spoons Stock Pops 40% as Berkshire Boosts Stake

Bending Spoons shares rose more than 40% in recent trading after Berkshire Hathaway increased its stake to 4%, investing a further $330 million. The company will issue Berkshire 10 million shares at $33 each in a private placement; Berkshire had previously invested $600 million at Bending Spoons’ IPO. Shares were around $54, versus a $40.50 close on their July 1 Nasdaq debut.

Analysis

Berkshire’s participation is a credibility signal, not a valuation floor: a 4% minority stake provides no control or assurance of future support. The immediate move appears to price that signal more than any demonstrated change in earnings power. The fixed $33 placement price is now well below the quoted market price, creating a potential supply/overhang concern—but resale restrictions, closing terms, and the post-issuance share count are not provided, so the near-term dilution and selling pressure cannot be quantified.

Over 1–3 months, the key test is whether Bending Spoons converts the capital and elevated equity currency into acquisitions that improve per-share economics. A higher share price can lower the effective cost of stock-funded deals, but also tempts a roll-up strategy to overpay; acquisition returns and integration execution matter more than headline deal volume. Over 6–18 months, weak returns or further equity issuance could expose the rally as multiple expansion without earnings support. Conversely, disclosed restrictions on placement shares and credible, accretive acquisition results would reduce the overhang. The principal contrarian risk to a bearish read is that Berkshire’s involvement may attract incremental buyers and sustain momentum longer than fundamentals warrant.

Key Decisions for Investors

• Do not chase BSP after the sharp repricing. Verify the fully diluted share count, placement closing conditions, and any resale/lock-up restrictions before sizing a position; these determine whether the $33 issuance is a real near-term supply risk.
• For existing BSP holders, consider trimming into strength rather than treating Berkshire’s stake as a downside backstop. Reassess if the company reports acquisition returns or guidance that supports per-share value creation.
• Set a 1–3 month watch on acquisition announcements and financing terms: favor evidence of accretive cash generation over deal count. Rising share issuance without corresponding improvement in per-share operating metrics would weaken the thesis.
• Avoid an outright short solely on the placement discount: float, borrow availability, and resale restrictions are unknown, while endorsement-driven momentum can persist. A sustained reversal of the post-news move alongside no evidence of accretive deployment would be a more actionable bearish trigger.